FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810931569> ?p ?o ?g. }

• W2810931569 endingPage "61" @default.
• W2810931569 startingPage "54" @default.
• W2810931569 abstract "Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in multiple tissues, including the small intestine. The effect of PCSK9 inhibition on cholesterol absorption is not known. Objectives: Measure serum cholesterol absorption markers before and after initiation of PCSK9 inhibitors. Methods: Single-center retrospective cohort of patients administered evolocumab and alirocumab between July 2015 and January 2017. Paired t tests were used to compare mean serum cholesterol marker concentrations, and ratios to total cholesterol, before and after PCSK9 inhibitor initiation. Analyses were repeated for those taking and not taking statins and taking or not taking ezetimibe at both initiation and follow-up, for each PCSK9 inhibitor, and based on follow-up time (<60, 60-120, and >120 days). Results: There were 62 possible participants, 34 were excluded for lack of data or unknown PCSK9 inhibitor initiation date. Average follow-up was 92.5 days. Mean campesterol (before 3.14 μg/mL, 95% CI: 2.79-4.38 μg/mL; after 2.09 μg/mL, 95% CI: 1.87-2.31 μg/mL; P < .0001), sitosterol (before 2.46 μg/mL, 95% CI: 2.23-2.70 μg/mL; after 1.62 μg/mL, 95% CI: 1.48-1.75 μg/mL; P < .0001), and cholestanol (before 3.25 μg/mL, 95% CI: 3.04-3.47 μg/mL; after 2.08 μg/mL, 95% CI: 1.96-2.21 μg/mL; P < .0001) all significantly decreased at follow-up. There was no significant change in absorption marker to total cholesterol ratios. Findings were not influenced by statin or ezetimibe use or nonuse, which PCSK9 inhibitor was prescribed, or time to follow-up. Conclusion: Proprotein convertase subtilisin/kexin type 9 inhibition was associated with decreased cholesterol absorption markers." @default.
• W2810931569 created "2018-07-10" @default.
• W2810931569 creator A5013947615 @default.
• W2810931569 creator A5018986102 @default.
• W2810931569 creator A5021947372 @default.
• W2810931569 creator A5055380940 @default.
• W2810931569 creator A5055767807 @default.
• W2810931569 creator A5074597860 @default.
• W2810931569 date "2018-06-25" @default.
• W2810931569 modified "2023-10-17" @default.
• W2810931569 title "The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients" @default.
• W2810931569 cites W1520609538 @default.
• W2810931569 cites W1888435097 @default.
• W2810931569 cites W1964532888 @default.
• W2810931569 cites W1972297695 @default.
• W2810931569 cites W1987168514 @default.
• W2810931569 cites W2001328643 @default.
• W2810931569 cites W2003121310 @default.
• W2810931569 cites W2003725537 @default.
• W2810931569 cites W2012468719 @default.
• W2810931569 cites W2013494570 @default.
• W2810931569 cites W2016253197 @default.
• W2810931569 cites W2020687765 @default.
• W2810931569 cites W2023855852 @default.
• W2810931569 cites W2047695409 @default.
• W2810931569 cites W2052011436 @default.
• W2810931569 cites W2052992240 @default.
• W2810931569 cites W2053087833 @default.
• W2810931569 cites W2066450795 @default.
• W2810931569 cites W2069390049 @default.
• W2810931569 cites W2078669364 @default.
• W2810931569 cites W2081123852 @default.
• W2810931569 cites W2098933462 @default.
• W2810931569 cites W2101139821 @default.
• W2810931569 cites W2108478956 @default.
• W2810931569 cites W2109607635 @default.
• W2810931569 cites W2119087485 @default.
• W2810931569 cites W2120991468 @default.
• W2810931569 cites W2136994561 @default.
• W2810931569 cites W2139066240 @default.
• W2810931569 cites W2154815373 @default.
• W2810931569 cites W2163448195 @default.
• W2810931569 cites W2166581542 @default.
• W2810931569 cites W2167612600 @default.
• W2810931569 cites W2169523655 @default.
• W2810931569 cites W2171029097 @default.
• W2810931569 cites W2190931206 @default.
• W2810931569 cites W2425255493 @default.
• W2810931569 cites W2596179513 @default.
• W2810931569 cites W3004056913 @default.
• W2810931569 cites W3185413432 @default.
• W2810931569 cites W69033956 @default.
• W2810931569 doi "https://doi.org/10.1177/1074248418780733" @default.
• W2810931569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29940784" @default.
• W2810931569 hasPublicationYear "2018" @default.
• W2810931569 type Work @default.
• W2810931569 sameAs 2810931569 @default.
• W2810931569 citedByCount "5" @default.
• W2810931569 countsByYear W28109315692020 @default.
• W2810931569 countsByYear W28109315692021 @default.
• W2810931569 countsByYear W28109315692022 @default.
• W2810931569 countsByYear W28109315692023 @default.
• W2810931569 crossrefType "journal-article" @default.
• W2810931569 hasAuthorship W2810931569A5013947615 @default.
• W2810931569 hasAuthorship W2810931569A5018986102 @default.
• W2810931569 hasAuthorship W2810931569A5021947372 @default.
• W2810931569 hasAuthorship W2810931569A5055380940 @default.
• W2810931569 hasAuthorship W2810931569A5055767807 @default.
• W2810931569 hasAuthorship W2810931569A5074597860 @default.
• W2810931569 hasConcept C126322002 @default.
• W2810931569 hasConcept C134018914 @default.
• W2810931569 hasConcept C2778114629 @default.
• W2810931569 hasConcept C2778163477 @default.
• W2810931569 hasConcept C2778657065 @default.
• W2810931569 hasConcept C2778718757 @default.
• W2810931569 hasConcept C2778824825 @default.
• W2810931569 hasConcept C2778849439 @default.
• W2810931569 hasConcept C2780072125 @default.
• W2810931569 hasConcept C2780745583 @default.
• W2810931569 hasConcept C2780902209 @default.
• W2810931569 hasConcept C2780948078 @default.
• W2810931569 hasConcept C2781471481 @default.
• W2810931569 hasConcept C43554185 @default.
• W2810931569 hasConcept C71924100 @default.
• W2810931569 hasConcept C72563966 @default.
• W2810931569 hasConcept C90924648 @default.
• W2810931569 hasConceptScore W2810931569C126322002 @default.
• W2810931569 hasConceptScore W2810931569C134018914 @default.
• W2810931569 hasConceptScore W2810931569C2778114629 @default.
• W2810931569 hasConceptScore W2810931569C2778163477 @default.
• W2810931569 hasConceptScore W2810931569C2778657065 @default.
• W2810931569 hasConceptScore W2810931569C2778718757 @default.
• W2810931569 hasConceptScore W2810931569C2778824825 @default.
• W2810931569 hasConceptScore W2810931569C2778849439 @default.
• W2810931569 hasConceptScore W2810931569C2780072125 @default.
• W2810931569 hasConceptScore W2810931569C2780745583 @default.
• W2810931569 hasConceptScore W2810931569C2780902209 @default.
• W2810931569 hasConceptScore W2810931569C2780948078 @default.

• next